Could Maternal RSV Vaccination Be the Preferred Option? - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Could Maternal RSV Vaccination Be the Preferred Option?

Survey respondents favored maternal vaccination over infant antibody administration, and physician recommendations increased acceptance among some hesitant participants.

  • By

  • Andrea Surnit

  • August 7, 2026

  • 4 min

Share

  • 1

    Pregnant women and parents preferred maternal vaccination over infant antibody administration for RSV protection.

  • 2

    Fifty-eight percent of pregnant women favored maternal vaccination, while only 6% preferred infant antibody shots.

  • 3

    A strong physician recommendation increased vaccine acceptance among hesitant respondents, with 36% of initially negative pregnant women willing to reconsider.

  • 4

    Concerns about vaccine safety for mothers and infants were the primary reasons for hesitancy among pregnant women.

  • 5

    The survey highlighted information gaps and the need for improved communication strategies regarding RSV immunization.

Original Source(s)

Could Maternal RSV Vaccination Be the Preferred Option?

  • by Andrea Surnit

  • August 7, 2026

Related Content

Indication-dependent heterogeneity in the effect of double-suture cerclage: concerns over indication classification and a call for stratified analysis

Pregnancy Risks With First Trimester GLP-1 Continuation

Claims-based target trial emulation found no clear association between continued GLP-1 receptor agonist use in early pregnancy and nonlive birth, fetal growth abnormalities, or major congenital malformations.

Certain Surgical Specialties See Greater Attrition

“Nearly one in every 10 surgeons left active clinical practice.”